Answers are grounded in this paper and cite their sources.
Conclusive evidence of a polyuric etiology from a failure of vasopressin elevation led to a new pharmacologic approach to the treatment of childhood nocturnal enuresis. Desmopressin acetate, a vasopressin analogue, has been used successfully since 1978 to treat this condition. Desmopressin's efficacy at doses of 5 to 40 micrograms has been demonstrated in Europe and the United States. Similarly, its safety has been established, and it is a first-line choice for physicians worldwide.
No takes yet. Share an insight, caveat, or question.
David A. Bloom (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: